Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal Approach

NCT07316296 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease (PD)
Freezing of Gait
Freezing of Gait Symptoms in Parkinson Disease

Interventions

DRUG: Atomoxetine
DRUG: Placebo

Sponsor

Radboud University Medical Center

Collaborators

[object Object]
[object Object]